Company

ACURA PHARMACEUTICALS, INC (0000786947)

Standardized SEC financial data for ACURA PHARMACEUTICALS, INC — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0000786947 · Pharmaceutical Preparations.

Gross margin

1.7%

Operating margin

-77.7%

Net margin

-56.2%

Revenue growth (YoY)

-56.2%

Return on equity

-493.8%

ROIC

-848.7%

Free cash flow

-$742K

Debt / equity

0.00×

Ratios for fiscal year 2021, standardized from SEC filings.

Income statement

USD	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021
Revenue	$4.5M	$107K	$410K	$2.7M	$3.6M	$1.6M
R&D expense	$4.0M	$3.7M	$1.8M	$1.5M	$1.8M	$1.5M
SG&A expense	$6.5M	$4.3M	$2.6M	$1.9M

Balance sheet

USD	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021
Cash & equivalents	$5.2M	$2.2M	$91K	$862K	$413K	$65K
Inventory	$341K	$0	—	—	—	—
Total current assets	$5.9M	$2.6M	$461K	$1.2M	$1.2M

Cash flow

USD	FY2018	FY2019	FY2019	FY2019	FY2020	FY2021
Operating cash flow	-$3.9M	—	—	-$618K	-$719K	-$742K
Investing cash flow	$0	—	—	—	—	—
Financing cash flow	$1.8M	—	—	$1.4M	$270K

Get 0000786947 data via API

# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0000786947/financials \
  -H "X-API-Key: YOUR_KEY"

# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0000786947/income-statement?format=csv" \
  -H "X-API-Key: YOUR_KEY"

Get a free API key Use with Claude (MCP) →View 0000786947 filings on SEC EDGAR →